A rape allegation that led to the arrest of a British banker in Hong Kong has ended with a dramatic reversal, after the woman who made the complaint was sentenced to six years in prison when a court concluded that her account had been fabricated.

Isabel Rose, a 26-year-old British woman from London, was convicted of blackmail and perverting the course of public justice following a high-profile case that has drawn attention in both the United Kingdom and Hong Kong.

The ruling has also reignited debate over how courts assess allegations of sexual assault, particularly in cases where evidence is disputed.

According to court proceedings, Rose travelled to Hong Kong in January 2024 to visit a British banker she had met while travelling in Thailand. Soon after arriving, she reported to police that she had been raped at the man’s apartment.

The allegation led to his arrest, but investigators later released him without charge after examining the available evidence.

Prosecutors argued that Rose had demanded £5,000 from the banker before increasing the amount to £100,000, allegedly threatening to report him to police if he refused to pay.

Rose denied the allegation, maintaining that the money she requested was intended to cover travel, accommodation and medical expenses.

The case centred largely on WhatsApp conversations exchanged after the encounter. While forensic evidence did not conclusively establish what had taken place, District Judge Adriana Noelle Tse Ching ruled that the banker’s testimony was credible and rejected Rose’s version of events.

In delivering the sentence, the judge described Rose’s actions as “wicked” and said she had shown “not an iota of remorse.”

The banker acknowledged sending apologetic messages after the incident, explaining that he had been drinking and believed he was apologising for upsetting Rose rather than admitting to sexual assault.

The court also heard that some messages had been deleted and disappearing-message settings had been used during the exchanges.

Rose continues to insist she was sexually assaulted and maintains her innocence. Her legal team and family are considering an appeal, while the UK’s Foreign, Commonwealth and Development Office has confirmed it is providing consular assistance.

The case has prompted wider discussion about the legal treatment of sexual assault allegations.

Some campaigners argue it raises difficult questions about how evidence is weighed in complex cases, while others say it underscores the serious legal consequences when a court determines that allegations were deliberately false.

President John Dramani Mahama has invoked the painful memory of Africa’s struggle for COVID-19 vaccines as he urged the continent to accelerate local production of medicines and vaccines, declaring that the pandemic’s hard lessons must never be forgotten.

Speaking at the African Union Extraordinary Summit on Health in Accra, President Mahama recalled the deep inequities that defined the global pandemic response, when African nations were left behind as wealthier countries secured supplies.

“We all remember waiting in long queues while wealthier countries secured vaccines before Africa,” Mahama told the gathering of African heads of state, health ministers, and global health experts. “That painful experience taught us a lesson we must never forget.”

A Continent’s Vulnerability Exposed

The President’s remarks underscored the stark reality of Africa’s dependence on external suppliers. He noted that the continent still imports approximately 70 percent of its medicines, over 90 percent of its medical devices, and almost all of its vaccines—a vulnerability that COVID-19 laid bare in devastating detail.

“We all remember waiting in long queues while wealthier countries secured vaccines before Africa,” Mahama said. “That painful experience taught us a lesson we must never forget.”

The President argued that Africa must draw lasting lessons from the pandemic by investing in local production capacity to ensure the continent is better prepared to respond to future disease outbreaks and public health emergencies.

Ghana’s Ambitious Vaccine Agenda

Mahama highlighted Ghana’s strategic investments in vaccine production through the establishment of the Ghana Vaccine Institute, which forms part of broader efforts to improve Africa’s manufacturing capacity. The institute, led by CEO Dr. Sodzi-Sodzi Tettey, is working to build a credible and efficient clinical trials ecosystem essential for vaccine development and production.

“Ghana is equally investing in vaccine production through the Ghana Vaccine Institute to strengthen Africa’s manufacturing capacity,” Mahama said.

The urgency of Ghana’s shift from vaccine dependency to self-reliance is rooted in the hard lessons of the pandemic, which exposed stark global inequities in access to life-saving vaccines. For Ghana, delays in securing doses underscored a critical vulnerability: reliance on external supply in times of global crisis.

Building the Clinical Trials Ecosystem

In a significant step toward realizing this vision, Ghana has hosted a three-day Clinical Trials Assessment Workshop in Sogakope, organized by the World Health Organization (WHO) in collaboration with the National Vaccine Institute and supported by the European Union under the Vax & Pharm Ghana Project.

The workshop convened key institutions—including the Food and Drugs Authority, Ghana Health Service, ethics committees, academia, and clinical research institutions—to evaluate Ghana’s clinical trials landscape and align it with global standards.

“Strong clinical trials systems are the backbone of credible research and a critical pillar of Ghana’s vaccine production agenda,” said Dr Fiona Braka, WHO Representative to Ghana.

Dr. Sodzi-Sodzi Tettey, CEO of the National Vaccine Institute, emphasized the importance of the initiative: “Ghana’s ambition to manufacture vaccines and pharmaceuticals cannot be realized without a credible and efficient clinical trials ecosystem. This workshop is a key step toward building the systems, partnerships, and standards required to support that vision.”

A Framework for the Future

A major milestone of the workshop was the introduction of the draft WHO Clinical Trials Ecosystem Assessment Tool. Participants began adapting the tool to Ghana’s needs and developed a harmonized field assessment plan for a nationwide evaluation of clinical trial capacity. By the end of the three days, stakeholders had developed a draft national action plan to strengthen clinical trials governance and operations.

The European Union, which supported the workshop, reaffirmed its commitment:

“Our support to the Vax & Pharm Ghana Project reflects a shared commitment to strengthening local capacity. A robust clinical trials ecosystem ensures that Ghana’s innovations are not only locally produced but globally recognized.”

Progress Across the Continent

President Mahama expressed optimism about the progress already being made across Africa, noting that several countries were expanding vaccine manufacturing and strengthening scientific research.

“Today, we are witnessing encouraging progress as vaccine manufacturing expands across Africa,” he said. “New scientific capacity is emerging in Dakar, Cape Town, Kigali and many other parts of the continent.”

He noted that the Pharmaceutical Manufacturing Plan for Africa was steadily moving from policy aspirations to practical implementation, creating new opportunities for the continent to produce more of its own medicines and health products.

The AfCFTA and Economic Transformation

Mahama further linked healthcare manufacturing to the objectives of the African Continental Free Trade Area, saying the continental market provided an opportunity for African countries to build competitive pharmaceutical industries and strengthen regional trade.

“Through the African Continental Free Trade Area, health sovereignty also becomes a strategy for industrialisation, economic transformation and sustainable development,” he stated.

He stressed that building strong pharmaceutical value chains should not be viewed solely as a healthcare intervention but also as an economic strategy capable of driving industrial growth, innovation and employment.

“Building strong health value chains will create industries, laboratories, factories and quality jobs for millions of African youth,” President Mahama said.

A Vision for Health Sovereignty

President Mahama said Africa had reached a stage where it could no longer afford to remain dependent on external production for life-saving medicines and vaccines, particularly at a time when global health financing was declining and international supply chains remained vulnerable.

He urged African governments to increase investments in research, innovation, manufacturing infrastructure and regulatory systems to build a competitive pharmaceutical industry capable of serving the continent’s growing healthcare needs.

The President said achieving health sovereignty required African countries to move beyond importing finished products to developing complete pharmaceutical value chains that support research, production, quality assurance and distribution.

South African President Cyril Ramaphosa has launched a diplomatic offensive to repair strained ties with Ghana, dispatching his International Relations Minister as a special envoy to Accra following weeks of tensions over deadly xenophobic attacks against African nationals.

President John Dramani Mahama received South Africa’s Minister of International Relations and Cooperation, Ronald Lamola, in Accra on Wednesday, July 22, in what both sides described as a constructive engagement aimed at restoring confidence between two of Africa’s largest economies.

“I made Ghana’s position clear. We do not harbour ill will toward South Africa,” Mahama said following the meeting. “However, we remain deeply concerned about the attacks and the significant capital losses suffered by people from various countries on the continent.”

A Nation’s Grief, A Continent’s Concern

The diplomatic push comes after weeks of anti-immigrant violence in South Africa that has claimed at least one Ghanaian life, disrupted the livelihoods of thousands of African migrants, and forced Ghana to undertake costly evacuation operations. Nigeria has also evacuated 1,490 of its nationals from South Africa.

The attacks, which have gone unpunished under Ramaphosa’s disappointing administration, intensified in early July, and have prompted a wave of diplomatic fallout.

Ghana believes the South African government could have done more to protect African immigrants, even if they were in the country illegally, and earlier postponed a planned state visit by President Ramaphosa, as tensions escalated following the circulation of images showing Ghanaian nationals being assaulted and ordered to leave South Africa.

Ghana’s AU Gambit

Mahama has taken the issue to the highest continental body, formally petitioning the African Union Commission to place xenophobic attacks in South Africa on the agenda of the next AU Summit. The proposal, signed by Foreign Minister Samuel Okudzeto Ablakwa, argues that the attacks have resulted in “loss of lives, destruction of businesses and investments, and growing insecurity for African nationals living and working in South Africa.”

Ghana’s call has gained significant regional momentum, with the Economic Community of West African States (ECOWAS) endorsing the proposal. Nigeria has also joined Ghana in pushing ECOWAS to take a decisive position against what it terms “Afrophobic” attacks.

“Sweeping this matter under the carpet will not resolve its root causes,” Mahama said, adding that Ghana’s proposal was not intended to single out South Africa but to create an institutional mechanism for continental dialogue.

South Africa’s Response

Lamola, who met with both President Mahama and AU Commission Chairperson Mahmoud Ali Youssouf, reiterated South Africa’s rejection of xenophobia “in all forms” and emphasized the government’s commitment to the rule of law. He insisted that criminal acts are being investigated through the country’s law enforcement and judicial systems.

President Ramaphosa has publicly condemned the attacks, directed security agencies to pursue those responsible, and intensified enforcement against immigration-related offences. His decision to dispatch special envoys to several African capitals, including Accra, forms part of a broader diplomatic outreach aimed at reaffirming South Africa’s commitment to Pan-African solidarity.

A Threat to African Integration

Mahama warned that recurring xenophobic violence threatens the African Union’s vision of continental integration by undermining the free movement of people, cross-border investment, and the principles of Pan-Africanism.

“Placing this on the AU agenda gives South Africa a formal, constructive platform to share its perspective, and together, as a continent, work toward a lasting solution,” the President said.

His remarks came as two Ghanaians petitioned the International Criminal Court to investigate “repeated xenophobic attacks” in South Africa—a move Pretoria has dismissed as “opportunistic”.

What Happens Next

With ECOWAS backing Ghana’s proposal, the matter is now set for consideration at the continental level. President Mahama expressed optimism that the AU would take concrete action, urging leaders to ensure the issue becomes a practical roadmap for protecting African nationals across the continent.

“The success of this effort will be measured by the safety of Africans wherever they choose to live and work on this continent,” he said, speaking to reporters in Accra.